Methyl 2-(4-(tert-butyl)phenoxy)acetate, 97.0%, 100mg

3,5-Dichloro-2-methoxypyridine, 98+%, 5g

Ethyl 1-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate, 95.0%, 5g

3-AZABICYCLO[3.2.0]HEPTANE HCL, 95.0%, 250mg

Methyl 4-cyano-3-nitrobenzoate, 97%, 100mg

GC capillary column ROTI®Cap-1, 15 m, 0.32 mm, 1.00 µm, 1 Piece(s)

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine, 98.0%, 100g

3-Bromo-6-chloro-2-fluorobenzoic acid, 97%, 5g

N-2-Chloroacetylurethane, 98.0%, 5g

4-FLUORO-3-NITROBENZENESULFONIC ACID, 95.0%, 100mg

1-Methyl-1,4-diazepan-2-one hydrochloride, 95.0%, 500mg

N1,N1,N3,N3-tetraethylpropane-1,3-diamine, 98%, 5g

5-Bromo-thiazol-2-ylamine, 96.0%, 1g